News AbbVie Inc.

Equities

ABBV

US00287Y1091

Real-time Estimate Cboe BZX Other stock markets 02:36:44 2023-12-11 pm EST			5-day change	1st Jan Change
150.97 ^USD	+1.13%		+4.81%	-6.51%

02:22pm	Goldman Sachs Upgrades AbbVie to Buy From Neutral, Raises Price Target to $173 From $149	MT
02:05pm	AbbVie, Genmab Report Strong, Durable Response Among Lymphoma Patients Treated With Epcoritamab	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Goldman Sachs Upgrades AbbVie to Buy From Neutral, Raises Price Target to $173 From $149	08:22am	MT
AbbVie, Genmab Report Strong, Durable Response Among Lymphoma Patients Treated With Epcoritamab	08:05am	MT
Genmab, AbbVie's Blood Cancer Drug Reduces Symptoms in Early-stage Study	01:23am	MT
News Highlights : Top Financial Services News of the Day	12:16am	DJ
Genmab A/S and AbbVie Announces New Pivotal Data for Bispecific Antibody Epcoritamab (Duobody CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma	Dec. 09	CI
Health Care Climbs as Deal Wave Seen Continuing -- Health Care Roundup	Dec. 08	DJ
S&P 500 Rises for Sixth Straight Week as Focus Shifts to Fed Meeting, Inflation Data	Dec. 08	MT
News Highlights : Top Financial Services News of the Day	Dec. 08	DJ
News Highlights : Top Company News of the Day	Dec. 07	DJ
AbbVie to focus on smaller deals after buying spree	Dec. 07	RE
Sector Update: Health Care Stocks Retreating Late Afternoon	Dec. 07	MT
Sector Update: Health Care Stocks Drop Thursday Afternoon	Dec. 07	MT
AbbVie-Cerevel Deal Makes 'Strategic Sense,' Mizuho Says	Dec. 07	MT
Sector Update: Health Care	Dec. 07	MT
AbbVie's $8.7 bln bet on Cerevel is risky but smart, analysts say	Dec. 07	RE
Bain scores over tenfold return with $8.7 billion Cerevel sale	Dec. 07	RE
Global markets live: AbbVie, McDonald's, Apple, AMD, Alphabet...	Dec. 07
Top Stories at Midday: Moody's Downgrades Chinese Banks; AbbVie Acquires Cerevel; Washington to Use March-In Law to Seize Pharma Patents; JetBlue Hikes Outlook	Dec. 07	MT
Biden Administration Launches Measures to Cut Health Care Costs; Proposes Use of 'March-In Rights' for Drugs	Dec. 07	MT
Trending : AbbVie to Buy Cerevel for $45 a Share	Dec. 07	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

News AbbVie Inc.

Equities

ABBV

US00287Y1091

Summary

Filters